Warning: Your browser doesn't support all of the features in this Web site. Please view our accessibility page for more details.

Quick Search [?]WHAT IS THIS?
Searches this and other areas of the Web site as you type. Results appear on this page.
Also searches the entire Web site (with results on a new page) if you press enter or click on 'Go'.

PUBLICATIONS

Pre-clinical Research

2013

Rea K, Olango WM, Harhen B, Kerr DM, Galligan R, Fitzgerald S, Moore M, Roche M, Finn DP (2013). Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocananbinoid-mediated fear-conditioned analgesia in rats. Pain doi S0304-3959(12)00682-3. 10.1016/j.pain.2012.12.021.

Kerr DM, Harhen B, Egan LJ, Finn DP, Roche M. (2013) Pharmacological inhibition of monoacylglycerol lipase attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action. British Journal of Pharmacology, doi: 10.1111/j.1476-5381.2012.02237.x.

2012

Roche M, Kerr DM, Hunt SP, Kelly JP (2012) Neurokinin 1 receptor deletion modulates behavioural and neurochemical alterations in an animal model of depression. Behavioural Brain Research 228: 91-98

Moriarty O, Roche M, McGuire BE, Finn DP (2012). Validation of an air-puff passive-avoidance paradigm for assessment of aversive learning and memory in rat models of chronic pain. J Neurosci Methods, 204(1):1-8.

Olango WM, Roche M, Ford GK, Harhen B, Finn DP (2012). The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone. Br J Pharmacol.,165(8):2549-60.

Kerr DM, Burke NN, Ford GK, Connor TJ, Harhen B, Egan LJ, Finn DP, Roche M (2012). Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor. Neuroscience, 204:53-63.

Butler RK, Ford GK, Hogan M, Roche M, Doyle KM, Kelly JP, Kendall DA, Chapman V, Finn DP (2012). Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: role of fatty acid amide hydrolase. J Psychopharmacol., 26(1):83-91.

Lang Y, Finn DP, Pandit A, Walsh PJ (2012). Pharmacological activity of ibuprofen released from mesoporous silica. J Mater Sci Mater Med., 23(1):73-80.

2011

Moriarty O, McGuire BE, Finn DP (2011). The effect of pain on cognitive function: a review of clinical and preclinical research. Progress in Neurobiology, 93(3):385-404.

Ford GK, Kieran S, Dolan K, Harhen B, Finn DP (2011). A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats. Pain,152(11):2495-504.

Butler RK, Nilsson-Todd L, Cleren C, Léna I, Garcia R, Finn DP (2011). Molecular and electrophysiological changes in the prefrontal contex-amygdala-dorsal periaqueductal grey pathway during persistent pain state and fear-conditioned analgesia. Physiology and Behavior, 24;104(5):1075-81.

Rea K, Roche M, Finn DP (2011). Modulation of conditioned fear, fear-conditioned analygesia and brain regional c-Fos expression following administration of muscimol into the rat basolateral amygdala. Journal of Pain,12(6):712-21.

Wang J, Zurawski TH, Meng J, Lawrence G, Olango WM, Finn DP, Wheeler L, Dolly JO (2011). A Di-leucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: Transfer of longevity to a novel potential therapeutic. J. Biol. Chem., 286(8):6375-85.

2010

McGuire BE (2010). Assessment of malingering and symptom magnification. In J. Kenardy & M. Sterling (Eds). Whiplash: Evidence base for clinical practice. ( Elsevier; In press).

Roche M, Johnston P, Mhuircheartaigh ON, Olango WM, Mackie K, Finn DP (2010). Effects of intra-basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear. European Journal of Pain, 14(5):487-95.

Burke NN, Hayes E, Calpin P, Moriarty O, Finn DP, Roche M (2010). Enhanced nociceptive responding in two rat models of depression is associated with alterations in monoamine levels in discrete brain regions. Neuroscience, 171:1300-1313.

Finn DP (2010). Endocannabinoid-mediated modulation of stress responses: physiological and pathophysiological significance. Immunobiology, 215(8): 629-646.

Roche M and Finn DP (2010). Brain CB₂ receptors: Implications for neuropsychiatric disorders. Pharmaceuticals, 3 (8), 2517-2553.

2009

Roche M, Johnston P, Ní Mhuircheartaigh O, Finn DP (2009). Effects of intra-basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear. European Journal of Pain (In Press PMID: 19786358).

Rea K, Lang Y, Finn DP (2009). Alterations in extracellular levels of gamma-aminobutyric acid in the rat basolateral amygdala and periaqueductal gray during conditioned fear, persistent pain and fear-conditioned analgesia. Journal of Pain, 10(10):1088-98.

Jones KL, Finn DP, Governo RJM, Prior MJ, Morris PG, Kendall DA, Marsden CA, Chapman V (2009). Identification of discrete sites of action of chronic treatment with desipramine in a model of neuropathic pain. Neuropharmacology, 56(2): 405-13.

Roche M, Finn DP (2009). 6-Iodonordihydrocapsaicin, xPharm; Executive Eds: SJ Enna and DB Bylund; Publisher, Elsevier, Inc., New York.

Ford GK, Finn DP (2009). PPAHV (Phorbol 12-phenylacetate 12-acetate 20-homovanillate), xPharm; Executive Eds: SJ Enna and DB Bylund; Publisher, Elsevier, Inc., New York.

Rea K, Finn DP (2009). SNC162, xPharm; Executive Eds: SJ Enna and DB Bylund; Publisher, Elsevier, Inc., New York.

Finn DP (2009). Endocannabinoid-mediated modulation of stress responses: physiological and pathophysiological significance. Immunobiology,

Butler RK, Finn DP (2009). Stress-induced analgesia. Progress in Neurobiology, 88, 184-202.

Rea K, Finn DP (2009). The Role of Supraspinal GABA and Glutamate in the Mediation and Modulation of Pain. In: Acute Pain: Causes, Effects and Treatment. Editors: Sam D'Alonso and Katherine L. Grasso © 2009 Nova Science Publishers, Inc. ISBN 978-1-60741-223-6.

2008

Butler RK, Rea K, Lang Y, Gavin AM, Finn DP (2008). Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates. Pain, 140, 491-500.

Roche M, Kelly JP, O’Driscoll M, Finn DP (2008). Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats. Immunology, 125(2): 263-271.

Ford GK, Moriarty, O, McGuire BE, Finn DP (2008). Investigating the effects of distracting stimuli on nociceptive behaviour and associated alterations in brain monoamines in rats. European Journal of Pain, 12(8): 970-979.

Hesketh SA, Brennan AK, Jessop DS, Finn DP (2008). Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions. Psychopharmacology, 198 (1): 29-36.

Ford GK, Finn DP (2008). Clinical correlates of Stress-induced Analgesia: Evidence from Pharmacological Studies. Pain, 140(1): 3-7.

2007

Roche M, O’Connor E, Diskin C, Finn DP (2007). The effect of CB₁ receptor antagonism in the right basolateral amygdala on
conditioned fear and associated analgesia in rats. European Journal of Neuroscience, 26 (9): 2643-2653.

Finn DP, Fone KCF, Beckett SRG, Baxter JA, Ansell L, Marsden CA, Chapman V (2007). The effects of pharmacological blockade of the 5-HT₆ receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal
axis activity in rats. European Journal of Pharmacology, 569(1-2): 59-63.

Rea K, Roche M, Finn DP (2007). Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate. British Journal of Pharmacology, 152 (5): 633-48

2006

Roche M, Diamond M, Kelly JP, Finn DP (2006). Cannabinoid receptor-mediated modulation of lipopolysaccharide-induced alterations in brain and peripheral cytokine levels, circulating lymphocytes and hypothalamo-pituitary-adrenal axis activity in rats in vivo. Journal of Neuroimmunology, 181(1-2): 57-67.

Finn DP, Jhaveri MD, Beckett SRG, Madjd A, Kendall DA, Marsden CA, Chapman V (2006). Behavioural, central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats. Neuroscience, 138(4): 1309-1317.

Psychological and Neuropsychological Aspects of Pain

2012

Raftery M, Ryan P, Normand C, Murphy, AW, De la Harpe D, McGuire BE (2012). The economic cost of chronic non-cancer pain in Ireland: Results from the PRIME study, Part 2. Journal of Pain, 13, 139-145.

McGuire BE, McManus S. (2012). Cognitive behavioural therapy for chronic pain in people with an intellectual disability: A case series using the Feeling Better programme. Journal of Intellectual Disability Research. (In press).

Fish R, Hogan M, Stewart I, Morrison T, McGuire BE (2012). Further validation of the CPAQ-8: A closer look at pain willingness ad activity engagement in chronic pain. Journal of Pain. (In press).

Fish R, Hogan M, Stewart I, Morrison T, McGuire BE (2012). Willing and able: A closer look at pain willingness and activity engagement in chronic pain. Journal of Pain. (In press). (Impact Factor 4.926).

MacNeela P, Doyle C, Mulveen R, O'Gorman D, Ruane N, McGuire BE (2012). Experiencing chronic low back pain: A meta-ethnography of qualitative research. ( Health Psychology Review). (Under revision). (Impact Factor 1.333).

2011

Walsh M, Morrison TM, McGuire BE (2011). Chronic pain in adults with an intellectual disability: Prevalence, impact and health service utilization based on carer report. Pain, 152, 1951-1957.

McGuire, BE (2011). Assessment of malingering and symptom magnification. In J. Kenardy & M. Sterling (Eds). Whiplash: Evidence base for clinical practice. Sydney: Elsevier.

Raftery M, Murphy AM, Normand C, De la Harpe D, Sarma K, McGuire BE (2011). Chronic pain in the Republic of Ireland – community prevalence, psychosocial profile and predictors of pain-related disability: Results from the PRIME study, Part 1. Pain, 152, 1096-1103.

McManus S, McGuire BE (2010). Feeling Better: A cognitive behavioural pain management programme for people with an intellectual disability. Brighton, UK: Pavilion Publishing, UK.

Walsh M, Morrison TM, McGuire BE (2010). Chronic pain in adults with an intellectual disability: Prevalence, impact and health service utilization based on carer report. Pain. (In Press).

McGuire BE, Daly P, Smyth F (2010). Chronic pain among people with an intellectual disability: Under-recognised and under-treated? Journal of Intellectual Disability Research, 54, 240-245.

Fish R, McGuire BE, Hogan M, Stewart I, Morrison T (2010). Validation of the Chronic Pain Acceptance Questionnaire (CPAQ) in an Internet sample and development and preliminary validation of the CPAQ-8. Pain, 149, 435-443.

MacNeela P, Gibbons A, Murphy A, McGuire BE (2010). “We need to get you focused”: General Practitioners’ representations of chronic low back pain patients. Qualitative Health Research, 20, 977-986.

2008

McGuire BE, Hogan MJ, Morrison TG (2008) Dimensionality and reliability assessment of the Pain Patient Profile questionnaire European Journal of Psychological Assessment, 24 , 22-26

Somerville S, McGuire BE, Main C (2008). Psychosocial aspects of lower back pain. Journal of the Irish College of General Practitioners, 25(2), 27-30.

Pain Treatment and Pain Management

2012

McGuire BE (2012). Chronic pain in people with an intellectual disability. Current Opinion in Psychiatry. (In press). (Invited review). (Impact Factor 3.053).

McManus S, McGuire BE (2012). Cognitive behavioural therapy for chronic pain in people with an intellectual disability using the Feeling Better programme: A case series. Journal of Intellectual Disability Research. (In press). (Impact Factor 1.853).

Fox L, Walsh J. O'Gorman D, Ruane N, Coughlan R, Casey J, McGuire BE (2012). The differential impact of cognative coping style on effectiveness of distraction or sensation-focused interventions in chronic pain patients. Clinical Journal of Pain. (In press). (Impact Factor 3.005).

Population and policy aspects of Pain

2012

Raftery M, Ryan P, Normand C, Murphy AW, De la Harpe D, McGuire BE (2012). The economic cost of chronic non-cancer pain in Ireland: Results from the PRIME study, Part 2. Journal of Pain, 13, 139-145. (Impact Factor 4.851).

2011

Raftery M, Murphy AM, Normand C, De la Harpe D, Sarma K, McGuire BE (2010). Chronic pain in the Republic of Ireland – community prevalence, psychosocial profile and predictors of pain-related disability: Results from the PRIME study, Part 1. Pain. 152, 1096-1103. (Impact Factor 5.355).

Walsh M, Morrison TM, McGuire BE (2011). Chronic pain in adults with an intellectual disability: Prevalence, impact and health service utilization based on carer report. Pain, 152, 1951-1957. (Impact Factor 5.355).

Integration of Pre-clinical pain Research and Clinical Practice

2011
Moriarty O, McGuire BE, Finn DP (2011). The effect of pain and its pharmacological treatment on cognitive function: A review of clinical and pre-clinical studies. Progress in Neurobiology, 93, 385-404. (Impact Factor 9.966).

2009

2008

Carney J, McDonnell JG, Ochana A, Bhinder R, Laffey JG (2008). The transversus abdominis plane block provides effective postoperative analgesia in patients undergoing total abdominal hysterectomy. Anesth Analg.;107(6):2056-60.PMID: 19020158

McDonnell JG, Curley G, Carney J, Benton A, Costello J, Maharaj C, Laffet JG (2008). The analgesic efficacy of transversus abdoninis plane block after cesarean section: A prospective randomized controlled trial, Anesth Analg, 106(1); 186-91, PMID: 18165577

2007

McDonnell JG, O'Donnell BD, Farrell T, Gough N, Tuite D, Power C, Laffey JG (2007). Transversus abdominis plane block: a cadaveric and radiological evaluation. Reg Anesth Pain Med.;32(5):399-404.PMID: 17961838.

Maharaj CH, McDonnell JG, Harte BH, Laffey JG (2007). A comparison of direct and indirect laryngoscopes and the ILMA in novice users: a manikin study. Anaesthesia.;62(11):1161-6.PMID: 17924898

McDonnell JG, Laffey JG (2007). Transversus abdominis plane block. Anesth Analg.;105(3):883.PMID: 17717264

McDonnell JG, O’Donnell B, Heffernan A, Power C, Laffey JG (2007). Transversus Abdominus Plane (TAP) Block for Abdominal Surgery: Anatomic and Radiologic study. Reg Anes Pain Med;32(5):399-404. [PMID: 17961838]

McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. (2007). The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg;104(1):193-7. Erratum in: Anesth Analg.;104(5):1108. PMID: 17179269.

Maharaj CH, Costello JF, McDonnell JG, Harte BH, Laffey JG (2007). The Airtraq as a rescue airway device following failed direct laryngoscopy: a case series. Anaesthesia;62(6):598-601.PMID: 17506739

2006

O'Donnell BD, McDonnell JG, McShane AJ (2006). The transversus abdominis plane (TAP) block in open retropubic prostatectomy. Reg Anesth Pain Med.;31(1):91. Erratum in: Reg Anesth Pain Med. 2006;31(3):286. McDonnell, John G [added]; McShane, Alan J [added].PMID: 16418039

Centre for Pain Research
National University of Ireland, Galway, University Road, Galway, Ireland.
Phone: +353 (0)91 493266 / 5280
E-mail: brian.mcguire

nuigalway.ie; david.finn

nuigalway.ie
This page was last updated Thursday, April 25, 2013